|
|
| |
|
|
A look at recent
trends and issues related to the FDA and the cGMPs. Topics covered
are selected based on needs of the firm and the industry/regulatory
issues that are "hot" at the time.
|
| |
|
|
- Describe events that are shaping regulatory agencies and the
pharma industry's compliance-related activities
- Describe trends in FDA-issued warning letters and FDA-483s
as well as industry recalls
- Identify proposed changes to GMPs in the US, Canada, and Europe
- Given a case, identify the consequences of not following GMP
|
| |
|
|
Presentation, case study, and discussion.
|
| |
|
|
Technical, supervisory,
and management personnel. |
| |
|
|
2
- 4 hours. |
| |
|
|
|
|